Kavanaugh William Michael 4
4 · CytomX Therapeutics, Inc. · Filed Dec 12, 2017
Insider Transaction Report
Form 4
Kavanaugh William Michael
CSO, Head Res.&Non-Clin. Dev.
Transactions
- Exercise/Conversion
Common Stock
2017-12-08$1.57/sh+5,130$8,079→ 19,047 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-12-08−5,130→ 240,912 totalExercise: $1.57Exp: 2025-02-08→ Common Stock (5,130 underlying)
Footnotes (1)
- [F1]This option vests 25% on January 9, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month.